Generic drugs for public health in India: …… Advantage India
M M Nagargoje, S S Chaudhary, H A Siddiqui et al. · MRIMS Journal of Health Sciences · 2017
Abstract onlyNot checked
Medicine: papers
Filters1 filter applied
Status
- No notice
- Not checked
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
101 papers4 with full textQuestions on this topic
Product attributes affecting the substitutability of saiga horn drinks among young adult consumers in Singapore
Hunter Lockwood Doughty, Nicholas Lim, Luis Roman Carrasco et al. · Conservation Science and Practice · 2021
Abstract onlyNot checked
How will the consumer behaviour of Russians change under the impact of the crisis caused by the pandemic?
Igor S. Berezin · Население и экономика · 2020
Abstract onlyNot checked
A systematic review on the cost‐effectiveness of the computer‐assisted orthopedic system
Hua Li, Tengfeng Zhuang, Wenrui Wu et al. · Health Care Science · 2022
Abstract onlyNot checked
A retrospective cross-sectional descriptive study to critically appraise the quality of reporting of health economic evaluations conducted in the Indian setting
Sandeep Kumar Gupta, Ravi Kant Tiwari, Raj Kumar Goel · Perspectives in Clinical Research · 2022
Abstract onlyNot checked
Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008–2012)
Dipika Bansal, Anil Bhagat, Fabrizio Schifano et al. · Journal of Epidemiology and Global Health · 2019
Abstract onlyNot checked
Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
Wills Hughes-Wilson, Ana Palma, Ad Schuurman et al. · Orphanet Journal of Rare Diseases · 2012
Full textCC BY
Drug shortages in Israel: regulatory perspectives, challenges and solutions
Eyal Schwartzberg, Denize Ainbinder, Alla Vishkauzan et al. · Israel Journal of Health Policy Research · 2017
Abstract onlyNot checked
Health-related quality of life of patients with HIV/AIDS at a tertiary care teaching hospital in Ethiopia
Yared Belete Belay, Eskinder Eshetu Ali, Beate Sander et al. · Health and Quality of Life Outcomes · 2021
Abstract onlyNot checked
When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs.
Alyssa Bilinski, Peter Neumann, Joshua Cohen et al. · PLoS Medicine · 2017
Abstract onlyNot checked
Health preferences and preventive care utilisation: How EQ-5D-5L health preferences may affect uptake
Dan Kelleher, Edel Doherty, Ciaran O'Neill · Preventive Medicine Reports · 2021
Abstract onlyNot checked
baokuan film sobre la leucemia mieloide crónica como impulsor de reformas en el sistema sanitario chino: el caso de Dying to Survive (2018)
Sergio Jesús Villén Higueras, Marta Cabrera Corres · Revista de Medicina y Cine / Journal of Medicine and Movies · 2022
Abstract onlyNot checked
The Primary Process and Key Concepts of Economic Evaluation in Healthcare
Younhee Kim, Yunjung Kim, Hyeon-Jeong Lee et al. · Journal of Preventive Medicine and Public Health · 2022
Abstract onlyNot checked
Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model.
R Scott Braithwaite, Cynthia Omokaro, Amy C Justice et al. · PLoS Medicine · 2010
Abstract onlyNot checked
Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries
The ACTION Study Group · BMC Medicine · 2015
Full textCC BY
Publicly Available Pricing Information for Orthopaedic Upper Extremity Procedures in the United States Lacks Transparency and Consistency Between Major Hospitals
M. Lane Moore, B.S., Jordan R. Pollock, B.S., Matthew K. Doan, B.S. et al. · Arthroscopy, Sports Medicine, and Rehabilitation · 2022
Abstract onlyNot checked
The direct medical costs of outpatient cares of Type 2 diabetes in Iran: A retrospective study
Majid Davari, Zahra Boroumand, Masoud Amini et al. · International Journal of Preventive Medicine · 2016
Abstract onlyNot checked
A cost-effectiveness analysis of capecitabine maintenance therapy versus routine follow-up for early-stage triple-negative breast cancer patients after standard treatment from a perspective of Chinese society
Ji-Bin Li, Zhuo-Chen Lin, Martin C. S. Wong et al. · BMC Medicine · 2022
Abstract onlyNot checked
Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis.
Joseph T Wu, Mark Jit, Yaming Zheng et al. · PLoS Medicine · 2016
Abstract onlyNot checked
Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs
Nigel S. Cook, Julie Cave, Anke-Peggy Holtorf · Frontiers in Medicine · 2019
Abstract onlyNot checked